Document is current
Any future updates will be listed below
-
Authors
Dharni, Khushdeep https://orcid.org/0000-0003-3422-3731
Singh, Arshdeep https://orcid.org/0000-0001-7163-0454
Sharma, Sonika https://orcid.org/0000-0003-1660-141X
Midha, Vandana https://orcid.org/0000-0003-0192-3969
Kaur, Kirandeep https://orcid.org/0000-0002-0951-7415
Mahajan, Ramit https://orcid.org/0000-0001-6726-6151
Dulai, Parambir S. https://orcid.org/0000-0002-9514-2321
Sood, Ajit https://orcid.org/0000-0001-6961-6389
- License Information
-
More Information
Article History
Received: 26 April 2023
Accepted: 12 July 2023
First Online: 3 October 2023
Declarations
:
: The study was approved by the institutional review board (IEC number DMCH/R&D/2020/23). The corresponding author had full access to the data in the study and final responsibility for the decision to submit for publication. This is a report derived from GBD 2019 database. Hence the patients were not directly involved. Appropriate consenting procedures were followed in the GBD 2019 study.
: The study was approved by the institutional review board (IEC number DMCH/R&D/2020/23).
: This is a review report derived from GBD 2019 database. Hence the patients were not directly involved. Appropriate consenting procedures were followed in the GBD 2019 study.
: Parambir S. Dulai has received grants from and/or consults for Takeda, Janssen, Pfizer, Abbvie, Gilead, BMS, Novartis, Lilly, Abivax, PreciDiag, Addiso, GSK and Prometheus. Ajit Sood reports receiving honorarium for speaker events from Pfizer India. KD, AS, SS, VM, KK and RM declare that they have no conflict of interest.
: The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/ findings and content of this article.
